Catalyst Wire Dossier Catalyst Wire Dossier

Allogeneic adoptive immune therapy

· Beijing 302 Hospital
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Allogeneic adoptive immune therapy, covering 2017-08-29 to 2024-01-05. Get the full timeline:

Most recent: Clinical Trial Update: Allogeneic Adoptive Immune Therapy for Advanced AIDS Patients [Phase 2]

See pricing